INEX SEEKS APPROVAL TO SPIN-OUT ASSETS INTO TEKMIRA PHARMACEUTICALS

Inex Pharmaceuticals Corporation ("INEX"; TSX: IEX) announced that it has filed with securities regulators in Canada and mailed to shareholders the information circular and proxy materials for the shareholders' meeting September 20, 2006 at which INEX will seek approval to spin-out the Company's technology, products, cash and partnerships into Tekmira Pharmaceuticals Corporation ("Tekmira").
Drug Newswire